CoChat

Bone marrow CD34+/B220+ progenitors target the inflamed brain and display in vitro differentiation potential toward microglia

Davoust, N., Vuaillat, C., Cavillon, G., Domenget, C., Hatterer, E., Bernard, A., Dumontel, C., Jurdic, P., Malcus, C., Confavreux, C., Belin, M. F., Nataf, S. · 2006 · The FASEB Journal
Cited by 62

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Recent evidence indicates that microglial cells may not derive from blood circulating mature monocytes as they express features of myeloid progenitors. Here, we observed that a subpopulation of microglial cells expressed CD34 and B220 antigens during brain development. We thus hypothesized that microglia, or a subset of microglial cells, originate from blood circulating CD34/B220 myeloid progenitors, which could target the brain under developmental or neuroinflammatory conditions. Using experimental allergic encephalomyelitis (EAE) as a model of chronic neuroinflammation, we found that a discrete population of CD34/B220 cells expands in both blood and brain of diseased animals. In EAE mice, intravenous transfer experiments showed that macrophage‐colony stimulating factor (M‐CSF) ‐expanded CD34 myeloid progenitors target the inflamed central nervous system (CNS) while keeping their immature phenotype. Based on these results, we then assessed whether CD34/ B220 cells display in vitro differentiation potential toward microglia. For this purpose, CD34/B220 cells were sorted from M‐CSF‐stimulated bone marrow (BM) cultures and exposed to a glial cell conditioned medium. Under these experimental conditions, CD34/B220 cells were able to differentiate into microglial‐like cells showing the morphological and phenotypic features of native microglia. Overall, our data suggest that under developmental or neuroinflammatory conditions, a subpopulation of microglial cells derive from CNS‐invading CD34/B220 myeloid progenitors.—Davoust, N., Vuaillat, C., Cavillon, G., Domenget, C., Hatterer, E., Bernard, A., Dumontel, C., Jurdic, P., Malcus, C., Confavreux, C., Belin, M. F., Nataf, S. Bone marrow CD34/B220 progenitors target the inflamed brain and display in vitro differentiation potential toward microglia. FASEB J. 20, 2081–2092 (2006)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.05-5593com

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 62

Metadata

Authors
Davoust, N., Vuaillat, C., Cavillon, G., Domenget, C., Hatterer, E., Bernard, A., Dumontel, C., Jurdic, P., Malcus, C., Confavreux, C., Belin, M. F., & Nataf, S.
Venue
The FASEB Journal
Publisher
Wiley
Published
2006-10
Volume
20
Issue
12
Pages
2081-2092
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2168083685
Cited by
62
References
6
FWCI
4.35
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bone marrow CD34+/B220+ progenitors target the inflamed brain and display in vitro differentiation potential toward microglia. https://app.cochat.ai/papers/10.1096/fj.05-5593com
The paper
Davoust, N., Vuaillat, C., Cavillon, G., Domenget, C., Hatterer, E., Bernard, A., Dumontel, C., Jurdic, P., Malcus, C., Confavreux, C., Belin, M. F., & Nataf, S. (2006). Bone marrow CD34+/B220+ progenitors target the inflamed brain and display in vitro differentiation potential toward microglia. The FASEB Journal. https://doi.org/10.1096/fj.05-5593com

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.